PubRank

Dolca Thomas

Author PubWeight™ 22.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res 2004 5.40
2 Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 2004 2.66
3 The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004 2.64
4 Clinical considerations for the development of biosimilars in oncology. MAbs 2015 1.71
5 Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma. PLoS Pathog 2008 1.60
6 Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis 2011 1.53
7 DEC-205/CD205+ dendritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp. Immunology 2007 1.19
8 An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation 2010 1.08
9 Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study. Clin J Am Soc Nephrol 2010 1.01
10 Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets. Transplantation 2005 0.94
11 Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study. Transpl Int 2012 0.93
12 Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation 2002 0.89
13 Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol 2011 0.85
14 Summary of roundtable discussion meeting: non-human primates to assess risk for EBV-related lymphomas in humans. J Immunotoxicol 2011 0.75